Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells

Plasma membrane biomarkers preferentially expressed in pancreatic beta cells useful in imaging or targeting beta cells

US Patent 8425878 · Granted Apr 23, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treating, detecting, and identifying compounds to trea2024
Compounds and methods for treating, detecting, and identifying compounds to trea2022
Genetic markers for predicting responsiveness to FPG-18 compound2019
Markers and methods for detecting posttraumatic stress disorder (PTSD)2018
Method of detecting phosphorylation state of beta-catenin2016
Methods for identifying and using organ-specific proteins in blood2016
Methods for identifying and monitoring drug side effects2015
Methods for identifying and using organ-specific proteins in blood2015
Molecules specifically binding pancreatic beta cells biomarkers2015
Molecules specifically binding pancreatic beta cells biomarkers2015
Molecules specifically binding pancreatic beta cells biomarkers2015
Use of gene expression signatures to determine cancer grade2014